Literature DB >> 6272968

Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization.

A K Saemundsen, D T Purtilo, K Sakamoto, J L Sullivan, A C Synnerholm, D Hanto, R Simmons, M Anvret, R Collins, G Klein.   

Abstract

Tissues from patients thought to have Epstein-Barr virus (EBV)-induced lymphoproliferative diseases were probed for EBV genomes using 2 independent hybridization techniques. Tissues from six patients with the X-linked lymphoproliferative syndrome, all five renal allograft recipients with immunoblastic sarcoma, and eight patients with diverse types of immunodeficiency and lymphoproliferative diseases such as fatal infectious mononucleosis or malignant lymphoma associated with antecedent immunodeficiency contained significant numbers of EBV genome equivalents per cell. The use of 2 hybridization probes is recommended to confirm the presence of EBV genomes. The finding of significant numbers of EBV genomes in tissues from patients with immunodeficiency suggests that EBV is the etiological agent of the associated lymphoproliferative diseases.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6272968

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  35 in total

1.  Detection of Epstein-Barr virus by in situ hybridization. Progress toward development of a nonisotopic diagnostic test.

Authors:  R Bashir; F Hochberg; R H Singer
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

Review 2.  Lymphoproliferative disease in organ transplant recipients.

Authors:  M A Nalesnik
Journal:  Springer Semin Immunopathol       Date:  1991

3.  The detection of Epstein-Barr virus in hairy cell leukemia cells by in situ hybridization.

Authors:  B C Wolf; A W Martin; R S Neiman; A J Janckila; L T Yam; A Caracansi; B A Leav; R Winpenny; D S Schultz; H J Wolfe
Journal:  Am J Pathol       Date:  1990-03       Impact factor: 4.307

4.  Membranous changes in primary malignant CNS lymphomas.

Authors:  F Slowik; K Jellinger
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

5.  Epstein-Barr virus specific antibodies in patients with coeliac disease.

Authors:  S Harada; J Greally; J Davis; N Synder; F Stevens; C McCarthy; D T Purtilo
Journal:  Ir J Med Sci       Date:  1985-11       Impact factor: 1.568

6.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

Authors:  J Locker; M Nalesnik
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

7.  AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization.

Authors:  S J Hamilton-Dutoit; G Pallesen; M B Franzmann; J Karkov; F Black; P Skinhøj; C Pedersen
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

8.  Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.

Authors:  E Vilmer; G M Lenoir; J L Virelizier; C Griscelli
Journal:  Clin Exp Immunol       Date:  1984-02       Impact factor: 4.330

9.  Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma.

Authors:  K Oda; J Tamaru; T Takenouchi; A Mikata; M Nunomura; N Saitoh; H Sarashina; N Nakajima
Journal:  Am J Pathol       Date:  1993-10       Impact factor: 4.307

10.  Detection of Epstein-Barr virus genomes in AIDS related lymphomas: sensitivity and specificity of in situ hybridisation compared with Southern blotting.

Authors:  S J Hamilton-Dutoit; H J Delecluse; M Raphael; G Lenoir; G Pallesen
Journal:  J Clin Pathol       Date:  1991-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.